Zacks: Analysts Anticipate Steris PLC (STE) Will Post Quarterly Sales of $665.47 Million
Equities research analysts predict that Steris PLC (NYSE:STE) will report sales of $665.47 million for the current quarter, Zacks reports. Three analysts have provided estimates for Steris’ earnings, with the highest sales estimate coming in at $669.90 million and the lowest estimate coming in at $661.50 million. Steris reported sales of $646.77 million during the same quarter last year, which indicates a positive year-over-year growth rate of 2.9%. The firm is expected to announce its next quarterly earnings report on Tuesday, February 6th.
On average, analysts expect that Steris will report full year sales of $665.47 million for the current fiscal year, with estimates ranging from $2.60 billion to $2.62 billion. For the next year, analysts expect that the company will report sales of $2.72 billion per share, with estimates ranging from $2.71 billion to $2.74 billion. Zacks’ sales calculations are an average based on a survey of research firms that follow Steris.
Steris (NYSE:STE) last announced its quarterly earnings results on Wednesday, November 1st. The medical equipment provider reported $0.94 EPS for the quarter, missing the Zacks’ consensus estimate of $0.95 by ($0.01). The company had revenue of $634.20 million during the quarter, compared to analysts’ expectations of $629.02 million. Steris had a return on equity of 11.49% and a net margin of 5.59%. Steris’s revenue for the quarter was down 1.9% on a year-over-year basis. During the same period last year, the firm earned $0.89 earnings per share.
In related news, VP John Adam Zangerle sold 3,650 shares of Steris stock in a transaction that occurred on Tuesday, November 14th. The stock was sold at an average price of $88.00, for a total transaction of $321,200.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, insider Michael J. Tokich sold 11,000 shares of Steris stock in a transaction that occurred on Monday, October 23rd. The shares were sold at an average price of $92.00, for a total value of $1,012,000.00. Following the sale, the insider now owns 58,588 shares in the company, valued at $5,390,096. The disclosure for this sale can be found here. Insiders have sold 36,650 shares of company stock worth $3,315,200 over the last three months. Insiders own 2.55% of the company’s stock.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. GSA Capital Partners LLP bought a new stake in shares of Steris during the third quarter valued at approximately $284,000. Neuberger Berman Group LLC boosted its position in shares of Steris by 10.8% during the third quarter. Neuberger Berman Group LLC now owns 9,083 shares of the medical equipment provider’s stock valued at $803,000 after purchasing an additional 886 shares in the last quarter. California Public Employees Retirement System boosted its position in shares of Steris by 7.1% during the third quarter. California Public Employees Retirement System now owns 211,344 shares of the medical equipment provider’s stock valued at $18,683,000 after purchasing an additional 14,062 shares in the last quarter. Zions Bancorporation bought a new stake in shares of Steris during the third quarter valued at approximately $178,000. Finally, Vident Investment Advisory LLC bought a new stake in shares of Steris during the third quarter valued at approximately $952,000. Institutional investors own 89.40% of the company’s stock.
Steris (NYSE:STE) opened at $89.09 on Tuesday. The company has a debt-to-equity ratio of 0.48, a current ratio of 2.80 and a quick ratio of 2.18. The company has a market capitalization of $7,585.82, a P/E ratio of 22.99 and a beta of 1.27. Steris has a 12 month low of $65.26 and a 12 month high of $93.39.
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, December 20th. Stockholders of record on Wednesday, November 22nd will be paid a dividend of $0.31 per share. The ex-dividend date of this dividend is Tuesday, November 21st. This represents a $1.24 annualized dividend and a dividend yield of 1.39%. Steris’s dividend payout ratio (DPR) is presently 73.81%.
Steris Company Profile
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.